Literature DB >> 28786178

First, do no harm: Generalized procreative non-maleficence.

Ben Saunders.   

Abstract

New reproductive technologies allow parents some choice over their children. Various moral principles have been suggested to regulate such choices. This article starts from a discussion of Julian Savulescu's Principle of Procreative Beneficence (PPB), according to which parents ought to choose the child expected to have the best quality of life, before combining two previously separate lines of attack against this principle. First, it is suggested that the appropriate moral principles of guiding reproductive choices ought to focus on general wellbeing rather than prioritizing that of the child and, second, that they ought to be non-maximizing (e.g. seeking the 'good enough' or to avoid harm). Though neither of these suggestions is entirely novel, combining them results in a new, and arguably more plausible, principle to regulate procreative choices, which I call the Principle of Generalized Procreative Non-Maleficence (PGPNM). According to this principle, the primary obligation on parents is not to cause harm to other people through their reproductive choices.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  Savulescu; altruism; beneficence; enhancement; procreation; reproductive choice; selection

Mesh:

Year:  2017        PMID: 28786178     DOI: 10.1111/bioe.12366

Source DB:  PubMed          Journal:  Bioethics        ISSN: 0269-9702            Impact factor:   1.898


  2 in total

1.  Human germline editing in the era of CRISPR-Cas: risk and uncertainty, inter-generational responsibility, therapeutic legitimacy.

Authors:  Sebastian Schleidgen; Hans-Georg Dederer; Susan Sgodda; Stefan Cravcisin; Luca Lüneburg; Tobias Cantz; Thomas Heinemann
Journal:  BMC Med Ethics       Date:  2020-09-11       Impact factor: 2.652

2.  Procreative Non-Maleficence: A South African Human Rights Perspective on Heritable Human Genome Editing.

Authors:  Donrich Thaldar; Bonginkosi Shozi
Journal:  CRISPR J       Date:  2020-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.